Kesari Santosh, Kim Ryung S, Markos Vassilios, Drappatz Jan, Wen Patrick Y, Pruitt Amy A
Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA 02115, USA.
J Neurooncol. 2008 Jun;88(2):175-83. doi: 10.1007/s11060-008-9545-1.
Adult brainstem gliomas (BSG) are uncommon and poorly understood with respect to prognostic factors. We retrospectively evaluated the clinical, radiographic, histologic, and treatment features from 101 adults with presumed or biopsy proven BSG to determine prognostic factors.
We reviewed the records of patients diagnosed from 1987-2005. We used Cox proportional hazard models to determine prognostic factors.
These 50 male and 51 female patients ranged in age from 18 to 79 years at diagnosis (median 36 years) with follow-ups from 1 to 261 months (median 47 months). The overall survival for all patients at 5 and 10 years was 58% and 41%, respectively, with a median survival of 85 months (range 1-228). Out of 24 candidate prognosis factors, we selected seven covariates for proportional hazards model by Lasso procedure: age of diagnosis, ethnicity, need for corticosteroids, tumor grade, dysphagia, tumor location, and karnofsky performance status (KPS). Univariate analysis showed that these seven factors are significantly associated with survival. Multivariate analysis showed that four covariates significantly increased hazard for survival: ethnicity, tumor location, age of diagnosis, and tumor grade.
In this study, we identified four prognostic factors that were significantly associated with survival in adults with BSGs. Overall, these patients have a better prognosis than children with BSGs reported in the literature. These results call for larger prospective studies to fully assess the importance of these factors in the clinical setting and to help stratify patients in future clinical studies.
成人大脑胶质瘤(BSG)较为罕见,关于其预后因素的了解也很少。我们回顾性评估了101例经推测或活检证实为BSG的成人患者的临床、影像学、组织学和治疗特征,以确定预后因素。
我们回顾了1987年至2005年诊断的患者记录。我们使用Cox比例风险模型来确定预后因素。
这50例男性和51例女性患者诊断时年龄在18至79岁之间(中位年龄36岁),随访时间为1至261个月(中位47个月)。所有患者5年和10年的总生存率分别为58%和41%,中位生存期为85个月(范围1至228个月)。在24个候选预后因素中,我们通过套索程序为比例风险模型选择了7个协变量:诊断年龄、种族、是否需要使用皮质类固醇、肿瘤分级、吞咽困难、肿瘤位置和卡诺夫斯基功能状态(KPS)。单因素分析表明,这7个因素与生存率显著相关。多因素分析表明,4个协变量显著增加了生存风险:种族、肿瘤位置、诊断年龄和肿瘤分级。
在本研究中,我们确定了4个与成人大脑胶质瘤患者生存显著相关的预后因素。总体而言,这些患者的预后比文献中报道的儿童大脑胶质瘤患者更好。这些结果需要更大规模的前瞻性研究,以充分评估这些因素在临床环境中的重要性,并有助于在未来的临床研究中对患者进行分层。